Publications by authors named "Kiyoshi Ashida"

Claim this Profile
T
The safety and effectiveness of vonoprazan-based eradication therapy; a prospective post-marketing surveillance.
Kiyoshi Ashida, Youichirou Honda, Katsuyuki Sanada, Yukiko Takemura, Shigeru Sakamoto

Expert Opin Drug Saf· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study.
Yoshikazu Kinoshita, Yuuichi Sakurai, Nobuyoshi Takabayashi, Kentaro Kudou, Takahiro Araki, Kiyoshi Ashida

Clin Transl Gastroenterol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy.
Haruhiko Ozaki, Satoshi Harada, Toshihisa Takeuchi, Shinpei Kawaguchi, Yoshiaki Takahashi, Kiyoshi Ashida

Digestion· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study.
Yuji Mizokami, Kazunori Oda, Nobuo Funao, Akira Nishimura, Satoshi Soen, Kiyoshi Ashida

Gut· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.
Takashi Kawai, Kazunori Oda, Nobuo Funao, Akira Nishimura, Yasushi Matsumoto, Kiyoshi Ashida

Gut· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory Research on Latent Esophageal Motility Disorders in Dysphagia Patients.
Shinpei Kawaguchi, Toshihisa Takeuchi, Yousuke Inoue, Yoshiaki Takahashi, Haruhiko Ozaki, Kiyoshi Ashida

Digestion· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole.
Kiyoshi Ashida, Katsuhiko Iwakiri, Naoki Hiramatsu, Yuuichi Sakurai, Tetsuharu Hori

World J Gastroenterol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis.
Katsuhiko Iwakiri, Yuuichi Sakurai, Madoka Shiino, Hiroyuki Okamoto, Kentaro Kudou, Kiyoshi Ashida

Therap Adv Gastroenterol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Albumin and apolipoprotein H mRNAs in human plasma as potential clinical biomarkers of liver injury: analyses of plasma liver-specific mRNAs in patients with liver injury.
Shingo Okubo, Makoto Miyamoto, Dai Ito, Kenji Takami, Kiyoshi Ashida

Biomarkers· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.
Yoshikazu Kinoshita, Yuuichi Sakurai, Madoka Shiino, Kentaro Kudou, Akira Nishimura, Kiyoshi Ashida

Curr Ther Res Clin Exp· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
Katsuhiko Iwakiri, Yoshikazu Kinoshita, Yasuki Habu, Tadayuki Oshima, Noriaki Manabe, Kiyoshi Ashida

J Gastroenterol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects.
Yuuichi Sakurai, Akira Nishimura, Gale Kennedy, Mark Hibberd, Richard Jenkins, Kiyoshi Ashida

Clin Transl Gastroenterol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
Yasuhiro Fujiwara, Yasuki Habu, Kiyoshi Ashida, Motoyasu Kusano, Kazuhide Higuchi

Digestion· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn's disease.
Takumi Fukuchi, Hiroshi Nakase, Satoshi Ubukata, Minoru Matsuura, Takuya Yoshino, Kiyoshi Ashida

BMC Gastroenterol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus.
Takumi Fukuchi, Hiroshi Nakase, Minoru Matsuura, Takuya Yoshino, Takahiko Toyonaga, Kiyoshi Ashida

J Crohns Colitis· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease.
Hiroshi Yamashita, Kiyoshi Ashida, Takumi Fukuchi, Yoshiaki Nagatani, Hideaki Koga

J Smooth Muscle Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors associated with the success of pneumatic dilatation in Japanese patients with primary achalasia: a study using high-resolution manometry.
Hiroshi Yamashita, Kiyoshi Ashida, Takumi Fukuchi, Yoshiaki Nagatani, Hideaki Koga

Digestion· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic evaluation of low-dose aspirin-induced gastric and duodenal ulcers during prophylaxis with lansoprazole.
Nobuhiro Sakaki, Kiyoshi Ashida, Yuji Mizokami, Tsutomu Chiba, Shigeyuki Matsui

Hepatogastroenterology· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
Kentaro Sugano, Teiji Kontani, Shinichi Katsuo, Yoshinori Takei, Nobuhiro Sakaki, Kiyoshi Ashida

J Gastroenterol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
Masahiro Sakaguchi, Miyuki Takao, Yasuo Ohyama, Hiroshi Oka, Hiroshi Yamashita, Kiyoshi Ashida

World J Gastroenterol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.
Kiyoshi Ashida, Yoshikazu Kinoshita, Michio Hongo,

Dig Dis Sci· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, single-arm study assessing the efficacy and safety of L: -menthol sprayed onto the gastric mucosa during upper gastrointestinal endoscopy.
Naoki Hiki, Michio Kaminishi, Satoshi Tanabe, Junko Fujisaki, Junji Yoshino, Kiyoshi Ashida

J Gastroenterol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
Kentaro Sugano, Yasushi Matsumoto, Tsukasa Itabashi, Sumihisa Abe, Nobuhiro Sakaki, Kiyoshi Ashida

J Gastroenterol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diagnosis of gastric ulcer in the elderly].
Kiyoshi Ashida, Takumi Fukuchi, Hiroshi Yamashita

Nihon Rinsho· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics affecting health-related quality of life (HRQOL) in Japanese patients with reflux oesophagitis and the effect of lansoprazole on HRQOL.
Michio Hongo, Yoshikazu Kinoshita, Hiroto Miwa, Kiyoshi Ashida

J Med Econ· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis